In the critical and consistently high-demand field of respiratory health, products that offer both efficacy and added benefits are essential. Mucipoly P 75 Tablet, a powerful combination of Acetylcysteine (300mg) and Pyridoxamine dihydrochloride (75mg), is a best-in-class product for the management of respiratory conditions. As a PCD pharma company, we recognize the consistent, high demand for such specialized products, making this a valuable asset for any pharma distributor or wholesaler.
Acetylcysteine is a well-established mucolytic agent that works by thinning and loosening mucus in the airways, making it easier to clear. This provides significant relief for patients with conditions like chronic bronchitis and cystic fibrosis. The addition of Pyridoxamine dihydrochloride, a powerful antioxidant, helps to mitigate oxidative stress, a key factor in many chronic diseases. This unique dual-action formula makes Mucipoly P 75 Tablet a highly trusted and effective option for healthcare professionals.
At Cafoli Lifecare, we are committed to providing our B2B pharma partners with high-quality, profitable products. Our Mucipoly P 75 Tablet is manufactured in state-of-the-art facilities with strict quality controls. By partnering with us, you gain access to a reliable supply of this essential medication and the comprehensive support needed to succeed in the wholesale pharma market. Choose this product to build a strong and reputable business in the respiratory segment.
Common side effects may include thirst, dry mouth, increased urination, dizziness, and weakness. Some patients may develop hypernatremia (elevated blood sodium), low blood pressure, or mild liver enzyme elevations. Rare but serious side effects include severe dehydration, kidney dysfunction, or allergic reactions. Patients experiencing severe or persistent symptoms should seek medical attention promptly.
Tolvise 30 Tablet is indicated for the treatment of hyponatremia (low blood sodium levels), particularly in patients with syndrome of inappropriate antidiuretic hormone secretion (SIADH), heart failure, or cirrhosis. Tolvaptan selectively blocks vasopressin V2 receptors in the kidneys, promoting excretion of free water while preserving essential electrolytes. This mechanism helps restore normal sodium levels, reduce fluid overload, and relieve symptoms such as edema, fatigue, and breathlessness, thereby improving overall fluid balance and patient well-being.
Tolvise 30 Tablet should be taken exactly as prescribed by a healthcare professional, usually once daily, with close monitoring of blood sodium levels. Excessive fluid intake should be avoided unless specifically advised by the physician. Caution is recommended in patients with liver impairment, kidney dysfunction, or low blood pressure. The medication should not be stopped abruptly without medical supervision, as sudden discontinuation may cause imbalances in sodium and fluid levels.
Store Tolvise 30 Tablet in a cool, dry place, below 25°C, away from direct sunlight and moisture. Keep the tablets in their original packaging and out of the reach of children. Do not use the tablets beyond the expiry date indicated on the label.